XML 27 R14.htm IDEA: XBRL DOCUMENT v3.24.3
Stock-Based Compensation
9 Months Ended
Sep. 30, 2024
Stock-Based Compensation  
Stock-Based Compensation

7. Stock-Based Compensation

Summary of Stock Option and Award Activity

The following table summarizes the stock option and award activity for the nine months ended September 30, 2024:

Options Outstanding

Weighted-

Weighted-

Options and

Average

Average

Aggregate

Awards

Exercise

Remaining

Intrinsic

Available for

Number of

Price Per

Contractual

Value

Grant

    

Options

    

Share

    

Life (years)

    

(In thousands)

Balance—December 31, 2023

 

598,397

1,829,428

$

5.96

6.9

$

5,676

Authorized

 

632,414

RSUs granted

(1,023,060)

RSUs cancelled/forfeited

220,678

Warrants exercised

Options granted

Options exercised

 

(116,842)

$

3.74

$

513

Options cancelled/forfeited

 

59,533

(60,147)

$

7.29

Balance—September 30, 2024

 

487,962

1,652,439

$

6.07

5.7

$

1,147

Options exercisable—September 30, 2024

 

1,424,898

$

5.90

5.5

$

1,120

The total grant date fair value of options vested was $0.3 million and $0.4 million during the three months ended September 30, 2024 and 2023, respectively, and $0.9 million and $1.7 million during the nine months ended September 30, 2024 and 2023, respectively.

No options were granted in the three months ended September 30, 2024 or 2023, respectively. No options were granted in the nine months ended September 30, 2024. The weighted-average grant date fair value of options granted was $3.85 per share during the nine months ended September 30, 2023.

As of September 30, 2024, there was $1.0 million of total unrecognized stock-based compensation expense related to unvested options which is expected to be recognized over a weighted-average period of 1.07 years. Stock-based compensation cost for options capitalized within inventory at September 30, 2024 and 2023, respectively, was not material.

2016 Employee Stock Purchase Plan

In January 2024, there was an increase of 210,804 shares reserved for issuance under the Company’s Employee Stock Purchase Plan (ESPP) pursuant to the terms of the ESPP. The Company had 1,063,270 shares available for future issuance under the Company’s ESPP as of September 30, 2024. Employees did not purchase any shares during the three months ended September 30, 2024 and 2023, respectively. Employees purchased 37,696 shares for $0.2 million during the nine months ended September 30, 2024. Employees purchased 40,894 shares for $0.2 million during the nine months ended September 30, 2023.

Restricted Stock Units

The following table summarizes restricted stock units (RSUs) activity for the nine months ended September 30, 2024:

RSUs Outstanding

    

Weighted-

    

Average

Number of

    

Grant Date

Restricted Stock

    

Fair Value Per

    

Units

    

Share

Balance—December 31, 2023

905,781

$

6.59

Granted

 

1,023,060

$

8.51

Vested

(598,031)

$

6.88

Cancelled/forfeited

(220,678)

$

8.16

Balance—September 30, 2024

 

1,110,132

    

$

7.89

The fair value of RSUs is determined on the date of grant based on the market price of the Company’s common stock on that date.

As of September 30, 2024, there was $7.5 million of unrecognized stock-based compensation expense related to RSUs to be recognized over a weighted-average period of 2.5 years. Stock-based compensation cost related to RSUs capitalized within inventory at September 30, 2024 and 2023, respectively, was not material.